Executive Vice Chair Department of Psychiatry
Psychiatry
Dr. Maurizio Fava, MD
|
|
Give Review
Maurizio Fava works in the field of Psychiatry. He studied medicine at University of Padua College of Medicine. He received awards:"Top MD". Dr. Maurizio Fava is also a published physician. He has 88 publication published. The most recent publication is: A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in major depressive disorder. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Effects of levomilnacipran ER on fatigue symptoms associated with Major depressive disorder.
- Relationship between placebo response rate and clinical trial outcome in bipolar depression.
- A placebo-controlled crossover study of iloperidone augmentation for residual anger and irritability in Major depressive disorder.
- Loss of sexual interest and premenstrual mood change in women with postpartum versus non-postpartum depression: A nationwide community sample of Korean adults.
- Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.
- Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controll...
- Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
- Response Surface Analysis and Non-Linear Optimization Algorithm For Maximization of Clinical Drug Performance: Application to Extended Release and Long-Acting-Injectab...
- Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant Major depressive disorder: A three week double ...
- The pro-inflammatory profile of depressed patients is (partly) related to obesity.
- Implications of a Biosignature Study of the Placebo Response in Major Depressive Disorder.
- Anxiety symptoms are linked to new-onset suicidal ideation after six months of follow-up in outpatients with Major depressive disorder.
- Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial.
- Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in Major depression.
- Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive Disorder.
- A Double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-L-methionine (SAMe) versus escitalopram in Major depressive disorder.
- Evaluation of Opioid Modulation in Major Depressive Disorder.
- Illness beliefs of Chinese American immigrants with Major depressive disorder in a primary care setting.
- Association between physician beliefs regarding assigned treatment and clinical response: Re-analysis of data from the Hypericum Depression Trial Study Group.
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Augmentation of a Nicotinic Acetylcholine Receptor Partial Agonist in Depression: Is There a Relati...
- Predictors of placebo response in bipolar depression.
- Further evidence for the reliability and validity of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ).
- The effects of co-morbidity in defining Major depression subtypes associated with long-term course and severity.
- Reliability and validity of the Symptoms of Depression Questionnaire (SDQ).
- Neural Predictors of Successful Brief Psychodynamic Psychotherapy for Persistent Depression.
- Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood Disorders.
- Sleep Quality, Posttraumatic Stress, Depression, and Human Errors in Train Drivers: A Population-Based Nationwide Study in South Korea.
- Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity Disorder but not autism spectrum Disorder in a large health system.
- S-adenosyl methionine (SAMe) versus escitalopram and placebo in Major depression RCT: Efficacy and effects of histamine and carnitine as moderators of response.
- Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may have biological validity: Implications for the Research Domain...
- An Electronic Health Records Study of Long-Term Weight Gain Following Antidepressant Use.
- Use of band-pass filter analysis to evaluate outcomes in an antidepressant trial for treatment resistant patients.
- Psychomotor symptoms and treatment outcomes of ziprasidone monotherapy in patients with Major depressive disorder: a 12-week, randomized, double-blind, placebo-control...
- Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from...
- Improvement in Subjective and Objective Neurocognitive Functions in Patients With Major Depressive Disorder: A 12-Week, Multicenter, Randomized Trial of Tianeptine Ver...
- Assessing response to treatment and recognizing residual Depressive symptoms.
- Rare Copy Number Variation in Treatment-Resistant Major Depressive Disorder.
- Correlates of irritability in college students with Depressive symptoms.
- The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with Major depressive disor...
- Conditional Probability of Response or Nonresponse of Placebo Compared With Antidepressants or St John's Wort in Major Depressive Disorder.
- CLINICAL RELEVANCE OF FATIGUE AS A RESIDUAL SYMPTOM IN Major DEPRESSIVE DISORDER.
- Female reproductive life cycle and hormones: methodology to improve clinical trials.
- Relationship Between Obesity and Depression: Characteristics and Treatment Outcomes With Antidepressant Medication.
- Evaluating Patient Acceptability of a Culturally Focused Psychiatric Consultation Intervention for Latino Americans with Depression.
- The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
- Combined MI + CBT for Depressive Symptoms and Binge Drinking Among Young Adults: Two Case Studies.
- Incentive salience: novel treatment strategies for Major depression.
- Childhood Parental Death and Lifetime Suicide Attempt of the Opposite-Gender Offspring in a Nationwide Community Sample of Korea.
- How can we make measures of psychotic depression symptoms more clinically useful?
- A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant Major depressive disorder.
- RELATIONSHIP BETWEEN SLEEP DISTURBANCE AND DEPRESSION, ANXIETY, AND FUNCTIONING IN COLLEGE STUDENTS.
- The evaluation of a culturally appropriate, community-based lifestyle intervention program for elderly Chinese immigrants with chronic diseases: a pilot study.
- Delayed Amnesic Syndrome after Riluzole Use in Major Depressive Disorder: A Case Report.
- A Double-blind, Placebo-Controlled Study of the Impact of Galantamine on Anterograde Memory Impairment During Electroconvulsive Therapy.
- Differential impact of isolated psychotic symptoms on treatment outcome of Major depressive disorder in the STAR*D cohort of Whites, Blacks and Latinos.
- Association Between Smoking and Heart Rate Variability Among Individuals with Depression.
- The effect of sildenafil on quality of life.
- Factors that distinguish college students with Depressive symptoms with and without suicidal thoughts.
- Melancholic features and hostility are associated with suicidality risk in Asian patients with Major depressive disorder.
- Do Menopausal Status and Use of Hormone Therapy Affect Antidepressant Treatment Response? Findings from the Sequenced Treatment Alternatives to Relieve Depression (STA...
- QT interval and antidepressant use: a cross sectional study of electronic health records.
- Compulsive use of alcohol among college students.
- A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.
- A pilot study of acupuncture monotherapy in patients with Major depressive disorder.
- A randomized, controlled, pilot study of acamprosate added to escitalopram in adults with Major depressive disorder and alcohol use disorder.
- A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for Major depressive disorder.
- The absence of Depressive symptoms is not the presence of wellness: Validation of the Clinical Positive Affect Scale.
- Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
- An exploratory study of combination buspirone and melatonin SR in Major Depressive Disorder (MDD): A possible role for neurogenesis in drug discovery.
- Cognitive therapy for anxious depression in STAR(â)D: What have we learned?
- Cross-cultural aspects of depression management in primary care.
- The Quick Inventory of Depressive Symptomatology, Clinician Rated and Self-report: A Psychometric Assessment in Chinese Americans With Major Depressive Disorder.
- CLINICAL OUTCOMES IN MEASUREMENT-BASED TREATMENT (COMET): A TRIAL OF DEPRESSION MONITORING AND FEEDBACK TO PRIMARY CARE PHYSICIANS.
- Tai Chi Treatment for Depression in Chinese Americans: A Pilot Study.
- Antidepressant effects on emotional temperament: toward a biobehavioral research paradigm for Major depressive disorder.
- Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in Major depressive disorder.
- Prevalence of MTHFR C677T and MS A2756G polymorphisms in Major depressive disorder, and their impact on response to fluoxetine treatment.
- Response to marks, abramowitz, and spielmans letter to the editor.
- What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?
- The importance of irritability as a symptom of Major depressive disorder: results from the National Comorbidity Survey Replication.
- Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.
- Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.
- Diurnal mood variation in outpatients with Major depressive disorder.
- Effectiveness of the relaxation response-based group intervention for treating depressed chinese american immigrants: a pilot study.
- Use of functional imaging across clinical phases in CNS drug development.
- The treatment of depressed chinese americans using qigong in a health care setting: a pilot study.
- Web-based depression screening and psychiatric consultation for college students: a feasibility and acceptability study.
Conditions Treated
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
Awards
- Top MD
Education
-
Massachusetts General Hospital -
University of Padua College of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1700858123 | |
| NPPES Provider LastName | FAVA | |
| NPPES Provider FirstName | MAURIZIO | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 574.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700858123 |
| Last Name Of The Provider | FAVA |
| First Name Of The Provider | MAURIZIO |
| View All |
Similar Doctors
|
|
Dr. Mark J. Viron, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily H. Mukherji, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Medoff, PHD |
|
|
Dr. Christopher R. Baca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew A. Nierenberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Tamara D. Almeyda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Malini Neramballi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard C. Pillard, MD
This Doctor is OpenDoctor Recommended.
|